Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
2.02
0.02 (1.00%)
At close: Aug 15, 2025, 3:47 PM

Caribou Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.67M 2.35M 2.08M 2.02M 3.46M 2.43M 3.56M 23.66M 3.75M 3.5M 3.69M 3.3M 4.19M 2.66M 2.56M 3.98M 1.48M 1.59M
Cost of Revenue
n/a n/a 1.18M 1.18M 856K 710K 1.97M -679K 1.13M 1.1M 903K 1.07M 858K 808K 273K 15.83M 12.33M 10.16M
Gross Profit
2.67M 2.35M 893K 2.02M 2.61M 1.72M 1.58M 24.34M 2.63M 2.4M 2.79M 2.23M 3.33M 1.86M 2.29M -11.86M -10.85M -8.58M
Operating Income
-47.58M -42.91M -38.88M -38.24M -43.5M -46M -37.44M -14.63M -32.87M -31.12M -30.58M -26.54M -28.43M -20.85M -20.41M -18.62M -15.96M -13.18M
Interest Income
n/a n/a n/a n/a n/a n/a 46K 4.77M 3.05M 2.83M n/a 1.47M n/a n/a 76K 22K 46K 4K
Pretax Income
-54.1M -39.99M -35.5M -34.68M -37.7M -41.23M -34.31M -10M -29.52M -28.04M -26.92M -26.65M -26.7M -19.09M -18.16M -20.97M -14.31M -13.16M
Net Income
-54.1M -39.99M -35.49M -34.68M -37.7M -41.23M -34.51M -10M -29.52M -24.99M -26.99M -26.76M -24.96M -17.32M -18.48M -20.97M -14.31M -13.16M
Selling & General & Admin
10.4M 9.73M 10.49M 9.84M 10.63M 14.64M 7.75M 9.71M 10.12M 8.91M 8.53M 9.85M 10.04M 9.59M 7.85M 6.76M 5.11M 4.6M
Research & Development
27.69M 35.53M 30.46M 30.42M 35.48M 33.79M 31.28M 28.58M 26.5M 25.71M 25.74M 19.99M 22.58M 13.92M 15.11M 15.83M 12.33M 10.16M
Other Expenses
12.15M n/a -1.18M n/a n/a -710K n/a -2.11M 3.33M 3.09M 3.72M -141K 1.75M 1.85M 2.17M -2.38M 25K 17K
Operating Expenses
50.24M 45.27M 39.77M 40.26M 46.11M 47.72M 39.03M 36.19M 36.62M 34.62M 34.27M 29.84M 32.62M 23.52M 22.96M 22.59M 17.44M 14.76M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 16K 88K n/a n/a 2K 5K
Selling & Marketing Expenses
n/a n/a n/a n/a -856K n/a -1.97M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
50.24M 45.27M 40.95M 40.26M 46.97M 48.43M 41M 38.3M 36.62M 34.62M 34.27M 29.84M 32.62M 23.52M 22.96M 22.59M 17.44M 14.76M
Income Tax Expense
n/a n/a -9K n/a n/a n/a 193K n/a n/a -3.06M 70K 110K -1.73M -1.76M 321K n/a 27K 22K
Shares Outstanding (Basic)
93.03M 92.68M 90.32M 90.46M 90.34M 89.3M 88.43M 83.78M 61.42M 61.19M 61M 60.89M 60.76M 60.55M 60.18M 45.89M 54.71M 27.66M
Shares Outstanding (Diluted)
93.03M 92.68M 90.32M 90.46M 90.34M 89.3M 88.43M 83.78M 61.42M 61.19M 61M 60.89M 60.76M 60.55M 60.18M 45.89M 54.71M 27.66M
EPS (Basic)
-0.58 -0.43 -0.39 -0.38 -0.42 -0.46 -0.39 -0.12 -0.48 -0.41 -0.44 -0.44 -0.41 -0.29 -0.31 -0.46 -0.26 -0.48
EPS (Diluted)
-0.58 -0.43 -0.39 -0.38 -0.42 -0.46 -0.39 -0.12 -0.48 -0.41 -0.44 -0.44 -0.41 -0.29 -0.31 -0.46 -0.26 -0.48
EBITDA
-34.26M -41.75M -34.43M -38.24M -42.65M -45.29M -36.7M -13.05M -32.25M -30.53M -32.65M -26.09M -28.07M -20.55M -17.89M -18.36M -15.73M -12.95M
EBIT
-35.43M -42.91M -35.62M -38.24M -43.5M -46M -37.44M -14.63M -32.87M -31.12M -30.58M -26.54M -28.43M -20.85M -18.16M -18.62M -15.96M -13.18M
Depreciation & Amortization
1.17M 1.17M 1.18M 1.18M 856K 710K 740K 1.58M 1.13M 1.1M 903K 1.07M 858K 808K 273K 260K 230K 221K